AGP Executive Report
Last update: 7 hours agoMovement & Blood Pressure: A Morocco study of 612 adults on hypertension treatment found 66% still had uncontrolled blood pressure, but moderate activity cut the odds by 51% and high activity by 69%, even after accounting for adherence. End-of-Life Policy: A federal judge let Illinois’ medical aid-in-dying law take effect Sept. 12, rejecting claims of likely harm while disability-rights cases involving religious providers continue. Medicare Pressure on Care: CMS is proposing to reduce Medicare reimbursement for same-day services by up to 50%, with Oklahoma physicians warning it could force more visits and disrupt rural care. Cancer Drug Shortages: A survey of 34 major U.S. cancer centers found shortages at nearly all sites, including ifosfamide (94%) and carboplatin (71%), often triggering repeat prior authorization. Community Pharmacy Care: Saskatchewan expanded strep throat and ear infection testing and treatment to 102 pharmacies, with services rolling out to more communities by Jan. 2027. Obesity Drug R&D: Corbus will discuss topline Phase 1b results for CRB-913 (CANYON-1) in an upcoming call, targeting obesity beyond GLP-1 approaches. Medicare Access Questions: Guidance pieces explain how to defer Medicare enrollment at 65 if covered by a creditable employer plan, and what to do when relocating.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.